Medico Remedies Limited submitted a formal response to BSE Limited regarding an email/query dated 3rd August 2026 concerning recent price movement in the company's shares.
The company explicitly stated that there is no pending information or announcement required to be disclosed under Regulation 30 of the SEBI (LODR) Regulations, 2015. Additionally, the company confirmed there are no other events or information that have any bearing on the company's operation or performance, including price sensitive information.
Regarding the specific price and volume movement referenced in the query, the company attributed these fluctuations purely to market conditions, describing them as "absolutely market driven" rather than resulting from any company-specific developments.
The disclosure emphasized the company's ongoing compliance with regulatory requirements, stating that Medico Remedies has been "regularly sharing all information/announcements of all material information/events with the stock exchange under the LODR regulations as and when such event occurs."
The letter was digitally signed by Haresh Mehta, Chairman & Whole-time Director (DIN: 01080289), on 5th August 2026 at 15:58:24 IST.